JUL 29, 2019 7:57 AM PDT

Medications Used for Atrial fibrillation May Increase Falls

WRITTEN BY: Nouran Amin

Falls among older adults are a growing health concern that often lead to injury, hospitalization, and other severe complications. Older adults are even at a higher risk of falling with debilitating chronic conditions and being prescribed certain drugs.

For example, atrial fibrillation—a condition characterized by the rapid contraction in one region of the heart—is most common among adults over 65 and is one of the major contributors to falling and fainting.

Learn more about atrial fibrillation:

Treatments for atrial fibrillation often include beta-blockers, certain calcium channel blockers (diltiazem, verapamil), and digoxin. Others drugs may also include amiodarone, flecainide, and propafenone. Unfortunately, these treatments increase the risk of falling among older adults but the connection to how this happens has not been studied until now

In a publication in the Journal of the American Geriatrics Society, researchers used data generated from Danish health records of atrial fibrillation patients between 65 and 100 years who were prescribed treatments. The researchers then examined those patients who had hospital admissions for falls or fainting and who suffered fall-related injuries such as varying degrees of head injuries or a fractured thigh, elbow, forearm, wrist, shoulder or upper arm, pelvis, and skull.

Results showed that patients who took amiodarone were at a significant risk of falling whether on short-term or long-term treatment and the medication digoxin held a slight association with fall-related injuries. In addition, treatments taken within the first 90 days, particularly the first two weeks, contributed to an even higher risk of injury.

"Our findings add evidence that, for older patients with atrial fibrillation, treatment with amiodarone is associated with a higher risk of fall-related injuries and fainting," stated the researchers.

Overall, the findings conclude the critical importance of health care providers weighing the pros and cons of reporting atrial fibrillation treatments to patients and the potential risk it may cause regarding their safety and patient care.

Source: Health in Aging

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAR 16, 2021
Drug Discovery & Development
Machine Learning Speeds Up Drug Discovery
MAR 16, 2021
Machine Learning Speeds Up Drug Discovery
How do drugs work? Well, they work when they stick to their target protein. Of course, there is much more complicated pr ...
MAR 24, 2021
Drug Discovery & Development
Three Compounds May Be Suitable for SARS-CoV-2
MAR 24, 2021
Three Compounds May Be Suitable for SARS-CoV-2
Researchers have found that that three common antiviral and antimalarial therapeutics may be effective in vitro at targe ...
APR 15, 2021
Drug Discovery & Development
Magic Mushroom Therapy and Antidepressants Produce Similar Results
APR 15, 2021
Magic Mushroom Therapy and Antidepressants Produce Similar Results
In recent years, psilocybin (the psychoactive ingredient in 'magic mushrooms') has gained increasing amounts of ...
APR 22, 2021
Drug Discovery & Development
New Method To Fast Track Drug Development
APR 22, 2021
New Method To Fast Track Drug Development
The time it takes to respond to disease outbreaks is critical. But designing drugs to combat these disease outbreaks is ...
JUN 09, 2021
Cell & Molecular Biology
Mechanism Linking Neurodegeneration & Brain Injury May Open Treatment Options
JUN 09, 2021
Mechanism Linking Neurodegeneration & Brain Injury May Open Treatment Options
Studies have shown that there is a link between blows to the head and neurodegeneration. Repeated head trauma is associa ...
JUN 14, 2021
Health & Medicine
Another Benefit of Aspirin: Decreased Colorectal Cancer Risk When Started Early
JUN 14, 2021
Another Benefit of Aspirin: Decreased Colorectal Cancer Risk When Started Early
Valued for stroke and heart attack prevention, aspirin is also recommended for colorectal cancer prevention. A Harv ...
Loading Comments...